Clinical Trials
4 trialsNCT03598595 2026-05-14
Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory Osteosarcoma
M.D. Anderson Cancer Center
Phase 1/2 Active not recruiting
NCT05036226 2026-05-13
COAST
Medical University of South Carolina
Phase 1/2 Recruiting
NCT04464759 2026-05-11
LIMIT
Abramson Cancer Center at Penn Medicine
Phase 1/2 Recruiting
NCT05842174 2026-04-16
TAQE
VA Office of Research and Development
Phase 1/2 Recruiting